New Research Funding

The Myrovlytis Trust has recently partnered with the Michigan High Throughput Screening Centerto undertake a first-stage drug screening project for BHD syndrome. This project will identify classes of compounds which have the potential to be developed as therapeutics and treat BHD syndrome in the future.